Ferrous fumarate with folic acid
Brand names: Galfer FA, Pregaday
A fixed-dose oral combination of the iron salt ferrous fumarate with folic acid, used to prevent iron and folate deficiency in pregnancy and to treat or prevent iron-deficiency anaemia where concurrent folate supplementation is wanted.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Ferrous fumarate provides elemental iron for haemoglobin synthesis and replenishment of iron stores, while folic acid is reduced to tetrahydrofolate, a cofactor for DNA synthesis and erythropoiesis.
Prescribing in practice
- The folic acid content is intended for routine antenatal supplementation and does not provide the higher dose needed for women at increased risk of neural tube defects, who require a separate high-strength folic acid product.
- Oral iron commonly causes gastrointestinal upset, constipation or dark stools, which can affect adherence; taking it with or after food and adjusting frequency may improve tolerability.
- Iron reduces absorption of several drugs including levothyroxine, bisphosphonates and certain antibiotics such as tetracyclines and quinolones, so doses should be separated.
Monitoring
Monitor the haemoglobin and, where relevant, iron indices to confirm an adequate response and guide duration of treatment.
Counselling the patient
- Stools may turn black, which is harmless, but seek advice if you have severe abdominal pain or persistent vomiting.
- Keep well out of the reach of children, as iron overdose is dangerous to young children.
- Separate this from indigestion remedies, calcium and certain other tablets by a couple of hours.
Evidence & guidelines
NICE antenatal care guidance supports folic acid supplementation in pregnancy and treatment of iron-deficiency anaemia, while reserving routine universal iron supplementation for those with demonstrated need.
Reference: NICE CG62/NG3; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Corrected Reticulocyte Count / Reticulocyte Production Index · Anaemia
- Ganzoni Equation for Iron Deficiency · Anaemia
- Transferrin Saturation Calculator · Anaemia / Iron Studies
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- Iron Deficiency Anaemia Calculator · Anaemia Assessment
- Ferritin Iron Store Interpretation · Haematological Values
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21